Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
US Market
Advertisement

Protagonist Therapeutics (PTGX) Technical Analysis

Compare
726 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Protagonist Therapeutics’s (PTGX) Moving Averages Convergence Divergence (MACD) indicator is 3.60, suggesting Protagonist Therapeutics is a Sell.
Protagonist Therapeutics’s (PTGX) 20-Day exponential moving average is 78.07, while Protagonist Therapeutics’s (PTGX) share price is $84.85, making it a Buy.
Protagonist Therapeutics’s (PTGX) 50-Day exponential moving average is 71.65, while Protagonist Therapeutics’s (PTGX) share price is $84.85, making it a Buy.

Protagonist Therapeutics (PTGX) Pivot Points

Nov 13, 2025, 07:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
80.71
81.85
83.71
84.85
86.71
87.85
89.71
Fibonacci
81.85
83.00
83.71
84.85
86.00
86.71
87.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Protagonist Therapeutics (PTGX) Moving Averages

Nov 13, 2025, 07:26 PM
Period
Simple
Exponential
MA5
82.59Buy
82.90Buy
MA10
79.98Buy
80.82Buy
MA20
77.87Buy
78.07Buy
MA50
70.09Buy
71.65Buy
MA100
62.46Buy
64.82Buy
MA200
54.10Buy
56.26Buy
Protagonist Therapeutics’s (PTGX) 10-Day exponential moving average is 80.82, while Protagonist Therapeutics’s (PTGX) share price is $84.85, making it a Buy.
Protagonist Therapeutics’s (PTGX) 100-Day exponential moving average is 64.82, while Protagonist Therapeutics’s (PTGX) share price is $84.85, making it a Buy.
Protagonist Therapeutics’s (PTGX) stock price is $84.85 and Protagonist Therapeutics’s (PTGX) 50-day simple moving average is 70.09, creating a Buy signal.
Protagonist Therapeutics’s (PTGX) stock price is $84.85 and Protagonist Therapeutics’s (PTGX) 100-day simple moving average is 62.46, creating a Buy signal.
Protagonist Therapeutics’s (PTGX) stock price is $84.85 and Protagonist Therapeutics’s (PTGX) 200-day simple moving average is 54.10, creating a Buy signal.

Protagonist Therapeutics (PTGX) Technical Indicators

Nov 13, 2025, 07:26 PM
Name
Value
Implied Action
RSI (14)
67.94
Neutral
STOCH (9,6)
86.94
Sell
STOCHRSI (14)
89.07
Sell
MACD (12,26)
3.60
Sell
ADX (14)
64.85
Sell
Williams %R
-15.69
Sell
CCI (14)
229.67
Sell
ATR (14)
3.34
-
Ultimate Oscillator
64.61
Neutral
ROC
14.69
Buy
Protagonist Therapeutics’s (PTGX) Relative Strength Index (RSI) is 67.94, creating a Neutral signal.
Protagonist Therapeutics’s (PTGX) Trend Strength Indicator (ADX) is 64.85, creating a Sell signal.
Protagonist Therapeutics’s (PTGX) Commodity Channel Index (CCI) is 229.67, creating a Sell signal.
Protagonist Therapeutics’s (PTGX) Price Rate of Change (ROC) is 14.69, creating a Buy signal.

FAQ

Is PTGX a Buy, Hold, or Sell?
Based on PTGX’s technical indicators, PTGX is a Buy.
    What is PTGX’s RSI (14)?
    PTGX’s RSI (14) is 67.94, which suggests PTGX is a Neutral.
      What is PTGX’s MACD?
      PTGX’s MACD is 3.60, which suggests PTGX is a Sell.
        What is PTGX’s 5-day moving average?
        PTGX’s 5-day moving average is 82.59, which suggests PTGX is a Buy.
          What is PTGX’s 20-day moving average?
          PTGX 20-day moving average is 77.87, which suggests PTGX is a Buy.
            What is PTGX’s 50-day moving average?
            PTGX’s 50-day moving average is 70.09, which suggests PTGX is a Buy.
              What is PTGX’s 200-day moving average?
              PTGX’s 200-day moving average is 54.10, which suggests PTGX is a Buy.
                What is PTGX’s Williams % R (14)?
                PTGX’s Williams % R (14) is -15.69, which suggests PTGX is a Sell.
                  What is PTGX’s CCI (14)?
                  PTGX’s CCI (14) is 229.67, which suggests PTGX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis